tradingkey.logo
tradingkey.logo

DaVita Inc

DVA
111.450USD
-1.140-1.01%
終値 01/09, 16:00ET15分遅れの株価
7.91B時価総額
11.23直近12ヶ月PER

DaVita Inc

111.450
-1.140-1.01%

詳細情報 DaVita Inc 企業名

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Incの企業情報

企業コードDVA
会社名DaVita Inc
上場日Oct 31, 1995
最高経営責任者「CEO」Rodriguez (Javier J)
従業員数76000
証券種類Ordinary Share
決算期末Oct 31
本社所在地2000 16th St
都市DENVER
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号80202-5117
電話番号13105362668
ウェブサイトhttps://www.davita.com/
企業コードDVA
上場日Oct 31, 1995
最高経営責任者「CEO」Rodriguez (Javier J)

DaVita Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.98K
+411.00%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.44K
+411.00%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
13.08K
-7501.00%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.23K
+411.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
他の
24.33M
0.71%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
他の
24.33M
0.71%

株主

更新時刻: Thu, Dec 4
更新時刻: Thu, Dec 4
株主統計
種類
株主統計
株主統計
比率
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
他の
39.97%
株主統計
株主統計
比率
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
他の
39.97%
種類
株主統計
比率
Holding Company
44.99%
Investment Advisor
25.80%
Investment Advisor/Hedge Fund
14.44%
Hedge Fund
5.47%
Individual Investor
5.06%
Research Firm
2.42%
Pension Fund
2.16%
Bank and Trust
0.87%
Sovereign Wealth Fund
0.35%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1272
36.41M
51.56%
-4.55M
2025Q3
1299
36.28M
57.59%
-1.47M
2025Q2
1288
37.75M
54.27%
+725.11K
2025Q1
1275
37.24M
54.43%
-4.83M
2024Q4
1234
39.31M
53.45%
-1.10M
2024Q3
1192
40.91M
54.63%
-1.68M
2024Q2
1162
42.62M
55.55%
-1.85M
2024Q1
1146
44.41M
55.70%
-4.44M
2023Q4
1143
45.66M
55.03%
+259.36K
2023Q3
1139
46.32M
54.25%
+1.22M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Berkshire Hathaway Inc.
31.76M
44.98%
-401.51K
-1.25%
Oct 27, 2025
The Vanguard Group, Inc.
4.21M
5.96%
-518.53K
-10.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
3.39%
-242.29K
-9.18%
Sep 30, 2025
Weschler (R Ted)
2.18M
3.09%
--
--
Aug 06, 2024
State Street Investment Management (US)
1.83M
2.6%
-258.50K
-12.35%
Sep 30, 2025
Invesco Capital Management LLC
1.40M
1.98%
+57.02K
+4.25%
Sep 30, 2025
Gates Capital Management, Inc.
1.19M
1.69%
+91.40K
+8.32%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.09M
1.54%
+88.06K
+8.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.45%
-86.31K
-7.78%
Sep 30, 2025
LSV Asset Management
927.03K
1.31%
-13.70K
-1.46%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Aztlan Global Stock Selection DM SMID ETF
2.59%
State Street SPDR S&P Health Care Services ETF
1.84%
Strategas Global Policy Opportunities ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.47%
Pacer US Cash Cows Growth ETF
1.02%
AdvisorShares Insider Advantage ETF
0.95%
Global X Aging Population ETF
0.75%
iShares U.S. Healthcare Providers ETF
0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.67%
LeaderShares AlphaFactor US Core ETF
0.66%
詳細を見る
Aztlan Global Stock Selection DM SMID ETF
比率2.59%
State Street SPDR S&P Health Care Services ETF
比率1.84%
Strategas Global Policy Opportunities ETF
比率1.64%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.47%
Pacer US Cash Cows Growth ETF
比率1.02%
AdvisorShares Insider Advantage ETF
比率0.95%
Global X Aging Population ETF
比率0.75%
iShares U.S. Healthcare Providers ETF
比率0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
比率0.67%
LeaderShares AlphaFactor US Core ETF
比率0.66%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

DaVita Incの上位5名の株主は誰ですか?

DaVita Incの上位5名の株主は以下のとおりです。
Berkshire Hathaway Inc.は31.76M株を保有しており、これは全体の44.98%に相当します。
The Vanguard Group, Inc.は4.21M株を保有しており、これは全体の5.96%に相当します。
BlackRock Institutional Trust Company, N.A.は2.40M株を保有しており、これは全体の3.39%に相当します。
Weschler (R Ted)は2.18M株を保有しており、これは全体の3.09%に相当します。
State Street Investment Management (US)は1.83M株を保有しており、これは全体の2.60%に相当します。

DaVita Incの株主タイプ上位3種は何ですか?

DaVita Incの株主タイプ上位3種は、
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

DaVita Inc(DVA)の株式を保有している機関の数はいくつですか?

2025Q4時点で、DaVita Incの株式を保有している機関は1272社あり、保有株式の総市場価値は約36.41Mで、全体の51.56%を占めています。2025Q3と比較して、機関の持ち株は-6.02%増加しています。

DaVita Incの最大の収益源は何ですか?

FY2025Q3において、Patient service - Medicare and Medicare Advantage部門がDaVita Incにとって最大の収益を生み出しており、その金額は1.72Bで、全収益の50.15%を占めています。
KeyAI